Filing Details

Accession Number:
0001140361-10-025261
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-11 13:00:00
Reporting Period:
2010-06-09
Filing Date:
2010-06-11
Accepted Time:
2010-06-11 15:16:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1254748 M Rebecca Henderson One Idexx Drive
Westbrook ME 04092
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-06-09 10,466 $62.29 8,348 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $62.2900 to $62.2950, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.